Provided by Tiger Fintech (Singapore) Pte. Ltd.

4D Molecular Therapeutics

3.06
+0.15005.15%
Post-market: 3.100.0400+1.31%19:58 EDT
Volume:377.85K
Turnover:1.14M
Market Cap:141.69M
PE:-1.03
High:3.07
Open:2.90
Low:2.89
Close:2.91
Loading ...
May 12, 2022

Major Issues Report

8-K - Current report
Apr 13, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 28, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2022

Major Issues Report

8-K - Current report
Oct 22, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 13, 2021

Major Issues Report

8-K - Current report
Sep 24, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Major Issues Report

8-K - Current report
Aug 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 06, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 25, 2021

Major Issues Report

8-K - Current report
May 20, 2021

Major Issues Report

8-K - Current report